🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this prospective open-label phase II study, is to evaluate t...
Status
Withdrawn
Location
Cedars-Sinai Medical Center
Start Date
2015-12
Trial ID
NCT02780882
Treatments Being Tested
5 month study comparing SOM230 s.c. and Sandostatin s.c. in acromegalic pat...
Status
Completed
Location
Cedars Sinai Medical Center
Start Date
2004-03
Trial ID
NCT00088582
Treatments Being Tested
The study treatment period is 15 days in length and includes patients with ...
Status
Completed
Location
Cedars-Sinai Pituitary Center
Start Date
2004-04
Trial ID
NCT00088608
Treatments Being Tested
This is a single-arm, open-label, phase I study of combination therapy with...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2011-09
Trial ID
NCT01434069
Treatments Being Tested
This is a monocenter, single-arm, open label phase II trial evaluating the ...
Status
Completed
Location
Klinik und Poliklinik für Neurologie der Universität Regensburg
Start Date
2012-03
Trial ID
NCT02021942
Treatments Being Tested
The purpose of the current study is to evaluate the efficacy and safety of ...
Status
Recruiting
Location
Mayo Clinic Arizona
Start Date
2025-05-30
Trial ID
NCT06784752
Treatments Being Tested
The purpose of this study is to see the safety and activity of using pasire...
Status
Completed
Location
Emory University Winship Cancer Institute
Start Date
2011-12
Trial ID
NCT01469572
Treatments Being Tested
Observe the safety/tolerability and effectiveness in terms of response rate...
Status
Withdrawn
Location
Penn State Milton S. Hershey Medical Center
Start Date
2010-12
Trial ID
NCT01234974
Treatments Being Tested
After failure of initial ADT, addition of an anti-androgen is established t...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-03-08
Trial ID
NCT01646684
Treatments Being Tested
This study will evaluate the efficacy and safety of pasireotide LAR 40 and ...
Status
Completed
Location
University of Michigan
Start Date
2010-07-19
Trial ID
NCT01137682
Treatments Being Tested